Same Indication

Lisinopril vs Tildrakizumab

Lisinopril vs Tildrakizumab: Overview

This comparison examines the pharmacological differences between Lisinopril and Tildrakizumab.

Mechanism of Action

Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

Pharmacokinetics

Half-life: Lisinopril — 12 hours.

Chemical Properties

Molecular Formula: Lisinopril — C21H31N3O5.

Molecular Weight: Lisinopril — 405.4900 g/mol.

Type: Lisinopril — Small molecule; Tildrakizumab — Antibody.